These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 26214430)

  • 1. Treatment of Moyamoya disease by multipoint skull drilling for indirect revascularization combined with mobilization of autologous bone marrow stem cells.
    Wu R; Su N; Zhang Z; Jia F
    Genet Mol Res; 2015 Jul; 14(3):7519-28. PubMed ID: 26214430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
    Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
    Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of autologous bone marrow stem cell mobilization combined with anti-infective therapy on moyamoya disease.
    Zhao L; Sun W; Liang H; Gao T; Liu Y; Sun Y; Zhang S; Li C
    Saudi J Biol Sci; 2020 Feb; 27(2):676-681. PubMed ID: 32210687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Randomized clinical study for two types of recombinant human granulocyte colony-stimulating factor mobilizing peripheral blood and bone marrow stem cells in patients receiving allogeneic hematopoietic stem cell transplantation].
    Zhang XH; Huang XJ; Liu DH; Liu KY; Han W; Chen H; Wang FR; Chen YH; Wang JZ; Zhao T; Wang Y; Xu LP
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2116-9. PubMed ID: 20058615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobilization of peripheral blood stem cells for autologous transplantation patients with hematological malignancies: Influence of disease, mobilization method, age and sex.
    Zhang C; Chen X; Zhang X; Gao L; Kong P; Wang Q; Peng X; Liu H
    Transfus Apher Sci; 2008 Aug; 39(1):21-8. PubMed ID: 18599353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation.
    Singhal S; Powles R; Kulkarni S; Treleaven J; Sirohi B; Millar B; Shepherd V; Saso R; Rowland A; Long S; Cabral S; Horton C; Mehta J
    Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human granulocyte colony-stimulating factor enhanced the resolution of venous thrombi.
    Chen YK; Jiang XM; Gong JP
    J Vasc Surg; 2008 May; 47(5):1058-65. PubMed ID: 18358673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: a single center experience from Turkey.
    Sivgin S; Karakus E; Kaynar L; Kurnaz F; Pala C; Keklik M; Zararsiz G; Solmaz M; Eser B; Cetin M; Unal A
    Transfus Apher Sci; 2013 Jun; 48(3):315-20. PubMed ID: 23611684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers.
    Goterris R; Hernández-Boluda JC; Teruel A; Gómez C; Lis MJ; Terol MJ; Tormo M; Solano C; Arbona C
    Bone Marrow Transplant; 2005 Nov; 36(10):847-53. PubMed ID: 16113660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with successful mobilization of progenitor hematopoietic stem cells among patients with lymphoid malignancies.
    Ameen RM; Alshemmari SH; Alqallaf D
    Clin Lymphoma Myeloma; 2008 Apr; 8(2):106-10. PubMed ID: 18501104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood stem cell mobilization failure.
    Kurnaz F; Kaynar L
    Transfus Apher Sci; 2015 Aug; 53(1):3-7. PubMed ID: 26074051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
    de Bont ES; Guikema JE; Scherpen F; Meeuwsen T; Kamps WA; Vellenga E; Bos NA
    Cancer Res; 2001 Oct; 61(20):7654-9. PubMed ID: 11606408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative expression of adhesion molecules on granulocyte colony-stimulating factor-mobilized peripheral blood, bone marrow, and cord blood CD34+ cells.
    Gigant C; Latger-Cannard V; Bensoussan D; Feugier P; Bordigoni P; Stoltz JF
    J Hematother Stem Cell Res; 2001 Dec; 10(6):807-14. PubMed ID: 11798507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The changes of stem cells, immune cells and cytokines in peripheral blood after marrow stem cell mobilization in macaqne].
    Pan XH; Pang RQ; He ZL; Wang HX; Zhang BZ; Zhao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jan; 24(1):13-5. PubMed ID: 18177609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Autologous Bone Marrow Stem Cell Therapy on the Levels of Inflammatory Factors and Conexin43 of Patients with Moyamoya Disease.
    Zhao L; Li T; Xue B; Liang H; Zhang S; Wu R; Guo G; Gao T; Liu Y; Sun Y; Li C
    Comput Intell Neurosci; 2022; 2022():7620287. PubMed ID: 36052043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
    Pandey P; Steinberg GK
    J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.